ABS Investment Management LLC Purchases New Shares in Sotera Health Company $SHC

Key Points

• ABS Investment Management initiated a 125,000-share position in Sotera Health during the second quarter, valued at approximately $2.2 billion and representing 1.5% of its portfolio. Institutional investors collectively own 91.03% of SHC.
• Sotera Health exceeded quarterly expectations, reporting $0.26 in EPS versus the $0.24 consensus and revenue of $321.38 million versus $309.70 million. Revenue increased 9.2% year over year, and management issued fiscal 2026 EPS guidance of $0.95–$1.01.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $21.50, above the stock’s reported $19.51 price. However, company insiders sold approximately $24 million in shares over the past 90 days.

ABS Investment Management LLC acquired a new stake in shares of Sotera Health Company (NASDAQ:SHC - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 125,000 shares of the company's stock, valued at approximately $2,218,750,000. Sotera Health accounts for about 1.5% of ABS Investment Management LLC's investment portfolio, making the stock its 16th biggest holding.

Several other institutional investors have also added to or reduced their stakes in the stock. Ancora Advisors LLC purchased a new stake in Sotera Health in the second quarter worth about $47,635,000. Canada Pension Plan Investment Board bought a new stake in shares of Sotera Health in the 2nd quarter worth approximately $754,000. Lakewood Capital Management LP bought a new stake in Sotera Health in the second quarter worth $70,638,000. Legal & General Group Plc bought a new position in Sotera Health in the 2nd quarter worth about $6,246,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Sotera Health during the second quarter valued at approximately $3,376,000. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Up 1.8%

NASDAQ SHC opened at $19.51 on Wednesday. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The stock has a 50 day moving average price of $17.89 and a 200-day moving average price of $16.36. The company has a market capitalization of $5.57 billion, a P/E ratio of 34.23 and a beta of 1.77.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The firm had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The business's quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, equities analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of recent analyst reports. Piper Sandler reaffirmed an "overweight" rating and set a $25.00 price target (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. The Goldman Sachs Group initiated coverage on Sotera Health in a report on Friday, June 5th. They set a "buy" rating and a $20.00 price target for the company. Weiss Ratings upgraded shares of Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Citigroup lifted their target price on shares of Sotera Health from $23.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $21.50.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares in the company, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael P. Rutz sold 150,000 shares of the business's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider owned 334,279 shares of the company's stock, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 over the last ninety days. 15.36% of the stock is owned by insiders.

Sotera Health Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source